Trials / Conditions / Generalized Lipodystrophy
Generalized Lipodystrophy
6 registered clinical trials studyying Generalized Lipodystrophy — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy NCT07220785 | Regeneron Pharmaceuticals | Phase 3 |
| Recruiting | Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy NCT06502990 | Amryt Pharma | Phase 3 |
| Active Not Recruiting | A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavad NCT06548100 | Regeneron Pharmaceuticals | Phase 3 |
| Completed | Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy NCT04159415 | Regeneron Pharmaceuticals | Phase 2 |
| Completed | Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy NCT04026178 | Aegerion Pharmaceuticals, Inc. | Phase 4 |
| Completed | Trial of Leptin Replacement Therapy in Patients With Lipodystrophy NCT00896298 | University of Texas Southwestern Medical Center | Phase 2 / Phase 3 |